Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3055089
Reference Type
Journal Article
Subtype
Review
Title
Gadolinium and lanthanum: a iatrogenic transmetallation?
Author(s)
Brambilla, S; Valaperta, S; Graziani, G; Montanelli, A
Year
2008
Is Peer Reviewed?
Yes
Journal
Clinical Biochemistry
ISSN:
0009-9120
EISSN:
1873-2933
Volume
41
Issue
13
Page Numbers
1029-1033
Language
English
PMID
18558088
DOI
10.1016/j.clinbiochem.2008.05.009
Web of Science Id
WOS:000258814500001
Abstract
An emerging skin disease inducing progressive severe dermal sclerosis and joint induration with severe movement restriction has been identified as Nephrogenic Systemic Fibrosis (NSF). In some patients NSF may rapidly progress and involve internal organs leading to fatal outcome. On May 2007 FDA issued a public health advisory concerning a possible link between NSF and exposure to gadolinium (an element of the lanthanides family) containing contrast agents used for Magnetic Resonance Angiography in advanced kidney failure (ESRD with GFR b30 mL/min) or in hemodialysis treated patients.
Keywords
Gadolinium; Lanthanum; Nephrogenic systemic fibrosis
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity